[go: up one dir, main page]

WO1993016178A3 - Sequences caracteristiques du produit de transcription des genes humains - Google Patents

Sequences caracteristiques du produit de transcription des genes humains Download PDF

Info

Publication number
WO1993016178A3
WO1993016178A3 PCT/US1993/001294 US9301294W WO9316178A3 WO 1993016178 A3 WO1993016178 A3 WO 1993016178A3 US 9301294 W US9301294 W US 9301294W WO 9316178 A3 WO9316178 A3 WO 9316178A3
Authority
WO
WIPO (PCT)
Prior art keywords
human gene
gene transcription
transcription product
sequences characteristic
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1993/001294
Other languages
English (en)
Other versions
WO1993016178A2 (fr
Inventor
Craig J Venter
Mark D Adams
Ruben F Moreno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of the Army
Original Assignee
United States Department of the Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Department of the Army filed Critical United States Department of the Army
Publication of WO1993016178A2 publication Critical patent/WO1993016178A2/fr
Publication of WO1993016178A3 publication Critical patent/WO1993016178A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Séquences d'ADNc humain et géniques partielles et complètes correspondant à des marques séquencielles exprimées particulières. Les marques séquencielles exprimées qui sont des séquences d'ADNc dont la longueur varie généralement entre 150 et 500 paires de bases sont dérivées de banques d'ADNc du cerveau humain, correspondent à des gènes transcrits dans le cerveau humain et possèdent des séquences de base désignées ici par les no. d'identification 1-2421.
PCT/US1993/001294 1992-02-12 1993-02-12 Sequences caracteristiques du produit de transcription des genes humains Ceased WO1993016178A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83719592A 1992-02-12 1992-02-12
US07/837,195 1992-02-12

Publications (2)

Publication Number Publication Date
WO1993016178A2 WO1993016178A2 (fr) 1993-08-19
WO1993016178A3 true WO1993016178A3 (fr) 1993-11-25

Family

ID=25273788

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/001294 Ceased WO1993016178A2 (fr) 1992-02-12 1993-02-12 Sequences caracteristiques du produit de transcription des genes humains

Country Status (2)

Country Link
AU (1) AU3665893A (fr)
WO (1) WO1993016178A2 (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014772A1 (fr) * 1993-11-12 1995-06-01 Kenichi Matsubara Signature genique
JPH09507751A (ja) 1993-12-24 1997-08-12 メディカル リサーチ カウンシル 多発性嚢胞腎１型遺伝子及びその使用
US5605797A (en) * 1994-09-15 1997-02-25 Board Of Trustees Operating Michigan State University Bovine β-mannosidase gene and methods of use
US5863744A (en) * 1994-10-03 1999-01-26 New England Deaconess Hospital Corporation Neural cell protein marker RR/B and DNA encoding same
US7175995B1 (en) 1994-10-27 2007-02-13 Thomas Jefferson University TCL-1 protein and related methods
US5985598A (en) * 1994-10-27 1999-11-16 Thomas Jefferson University TCL-1 gene and protein and related methods and compositions
US5985554A (en) * 1994-11-02 1999-11-16 Takeda Chemical Industries, Ltd. Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides
EP0851869A4 (fr) * 1995-06-30 2002-08-14 Human Genome Sciences Inc Genes et proteines specifiques au sein
US5695937A (en) * 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
AU4105396A (en) 1995-11-02 1997-05-29 Human Genome Sciences, Inc. Mammary transforming protein
US6509170B1 (en) 1996-03-14 2003-01-21 Human Genome Sciences, Inc. Polynucleotides encoding human tumor necrosis factor delta
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6468766B1 (en) 1996-03-15 2002-10-22 President And Fellows Of Harvard College Aortic carboxypeptidase-like polypeptide
JP2000513212A (ja) * 1996-05-06 2000-10-10 カイロン コーポレイション 哺乳動物の中肢性コーム（哺乳動物Ｓｃｍ）はガン遺伝子として作用する
JP2001519652A (ja) * 1996-05-08 2001-10-23 カイロン コーポレイション 哺乳動物の付加性コーム（哺乳動物Ａｓｘ）は腫瘍サプレッサーとして作用する
WO1998002541A1 (fr) 1996-07-12 1998-01-22 Genentech, Inc. Gamma-hereguline
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein
US5917028A (en) * 1996-10-29 1999-06-29 Incyte Pharmaceuticals, Inc. Human phosphoprotein
US5840559A (en) * 1996-10-30 1998-11-24 Incyte Pharmaceuticals, Inc. Human spermidine/spermine N1-acetyltransferase
US5889170A (en) * 1997-01-31 1999-03-30 Incyte Pharmaceuticals, Inc. Human integral membrane protein
US5939271A (en) * 1997-02-19 1999-08-17 The Regents Of The University Of California Netrin receptor
US5955312A (en) * 1997-02-24 1999-09-21 Incyte Pharmaceuticals, Inc. DNA encoding a novel microtubule-associated protein
JP2002508655A (ja) * 1997-02-26 2002-03-19 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
US6171787B1 (en) * 1997-06-26 2001-01-09 Abbott Laboratories Member of the TNF family useful for treatment and diagnosis of disease
US5948619A (en) * 1997-07-31 1999-09-07 Incyte Pharmaceuticals, Inc. Human zygin-1
WO1999009158A1 (fr) * 1997-08-13 1999-02-25 Chugai Research Institute For Molecular Medicine, Inc. PROTEINE PRESENTANT UN MOTIF Zn DU TYPE DOIGT
US6562949B1 (en) 1997-10-28 2003-05-13 Immunex Corporation Antibodies to viral encoded semaphorin protein receptor polypeptides
US7214497B2 (en) 1997-10-28 2007-05-08 Immunex Corporation Viral encoded semaphorin protein receptor DNA and polypeptides
WO1999021997A1 (fr) * 1997-10-28 1999-05-06 Immunex Corporation Adn et polypeptides recepteurs des proteines de semaphorine a codage viral
US6130068A (en) * 1998-10-26 2000-10-10 Immunex Corporation Viral encoded semaphorin protein receptor DNA and polypeptides
US6277565B1 (en) * 1997-11-06 2001-08-21 Millennium Pharmaceuticals, Inc. OCT-3 gene encoding transporter-like molecules
US5916753A (en) * 1997-11-13 1999-06-29 Incyte Pharmaceuticals, Inc. SH3-containing proteins
EP1103604A4 (fr) * 1998-07-29 2002-10-31 Kyowa Hakko Kogyo Kk Nouveau polypeptide
AU767263B2 (en) * 1998-10-09 2003-11-06 Genset Nucleic acids encoding human CIDE-B protein and polymorphic markers thereof
US6355788B1 (en) 1998-10-15 2002-03-12 Zymogenetics, Inc. Follistatin-related protein zfsta2
WO2000022126A1 (fr) * 1998-10-15 2000-04-20 Zymogenetics, Inc. La proteine zfsta2 apparentee a la follistatine
CA2355074A1 (fr) * 1998-12-18 2000-06-29 Incyte Pharmaceuticals, Inc. Proteines membranaires lymphocytaires
IL178921A0 (en) 1998-12-24 2007-03-08 Yeda Res & Dev Caspase-8 interacting proteins
GB9900167D0 (en) * 1999-01-06 1999-02-24 Univ Leeds Wound an tissue healing and orofacial clefting
DE19908423A1 (de) * 1999-02-26 2000-08-31 Deutsches Krebsforsch An der Entwicklung des ZNS beteiligtes Protein (TP)
JP2002537832A (ja) * 1999-03-09 2002-11-12 シエーリング アクチエンゲゼルシャフト 内皮細胞由来のヒト核酸配列及びタンパク質配列
AU773600B2 (en) 1999-09-10 2004-05-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The T2R, taste receptor family
US6558910B2 (en) * 1999-09-10 2003-05-06 The Regents Of The University Of California SF, a novel family of taste receptors
WO2001030845A1 (fr) * 1999-10-22 2001-05-03 American Home Products Corporation Pablo, polypeptide qui interagit avec bcl-xl, et ses utilisations
US20030153015A1 (en) * 2000-01-20 2003-08-14 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2001055300A2 (fr) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps
AU2001256998A1 (en) * 2000-04-11 2001-11-07 Cogent Neuroscience, Inc. Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
EP1209229A1 (fr) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gène impliqué dans la schizophrénie
WO2002052005A1 (fr) * 2000-12-22 2002-07-04 Kazusa Dna Research Institute Foundation Genes et proteines codees par ceux-ci
US7736654B2 (en) 2001-04-10 2010-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
US7189820B2 (en) 2001-05-24 2007-03-13 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (APRIL)
WO2004016733A2 (fr) 2002-08-16 2004-02-26 Agensys, Inc. Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers
ES2949159T3 (es) 2010-05-06 2023-09-26 Novartis Ag Composiciones y métodos de uso para anticuerpos terapéuticos de proteína 6 relacionada con lipoproteínas de baja densidad (LRP6)
AU2011249782B2 (en) 2010-05-06 2014-10-02 Novartis Ag Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (LRP6) multivalent antibodies
WO2013067355A1 (fr) 2011-11-04 2013-05-10 Novartis Ag Constructions de protéine 6 liée à la lipoprotéine de basse densité (lrp6) prolongeant leur demi-vie

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NATURE vol. 355, 13 February 1992, LONDON, UNITED KINGDOM pages 632 - 634 M.D. ADAMS 'Sequence Identification of 2375 human brain genes' *
SCIENCE vol. 252, 21 June 1991, WASHINGTON, DC, USA pages 1651 - 1656 M.D. ADAMS ET AL. 'Complementary DNA Sequencing: Expressed Sequence Tags and Human genome Projects' *

Also Published As

Publication number Publication date
AU3665893A (en) 1993-09-03
WO1993016178A2 (fr) 1993-08-19

Similar Documents

Publication Publication Date Title
WO1993016178A3 (fr) Sequences caracteristiques du produit de transcription des genes humains
AU5914196A (en) Hydrophobins from edible fungi, genes, nucleotide sequences and dna-fragments encoding for said hydrophobins, and expression thereof
CA2053230A1 (fr) Genes de pommes de terre .alpha. -amylase
WO1999006552A3 (fr) Est 5' pour proteines secretees exprimees dans le cerveau
CA2200371A1 (fr) Gene humain npik
WO1994001548A3 (fr) Fragments d'acide nucleiques humains isoles du cerveau, des tissus surrenaux, du placenta ou de la moelle osseuse
RU93058460A (ru) Полинуклеотид, способы получения растений, геном растения, клетки, плоды, семена, способы получения семян, применение олигонуклеотида, плазмида, микроорганизм
WO1999053051A3 (fr) Etiquettes de sequences exprimees (est) des 5' et proteines humaines codees
EP1754789A3 (fr) Souches de bacillus et protéines pesticides
WO1999006554A3 (fr) Est 5' pour proteines secretees exprimees dans des tissus musculaires et autres tissus mesodermiques
WO1999006550A3 (fr) Marqueurs sequences 5' exprimes pour proteines secretees exprimees dans la prostate
CY1106216T1 (el) 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ
AU2240492A (en) Sequences characteristic of human gene transcription product
CA2153254A1 (fr) Clonage d'enterokinase et methode d'utilisation
WO1999006549A3 (fr) Est 5' pour proteines exprimees dans les testicules et autres tissus
AU4331497A (en) Oligomers which inhibit expression of interleukin genes
WO1999006551A3 (fr) Est 5' pour proteines secretees identifiees dans le tissu cerebral
AU2967497A (en) Enhancement of gene expression
PL331542A1 (en) Immunity against nematodes and/or plant louses
AU6724794A (en) GRB3-3 gene, its variants and their uses
AU1789292A (en) Yeast promoter and use thereof
WO1999046374A3 (fr) Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
WO1999054447A3 (fr) Sequences d'acide nucleique provenant de tissus tumoraux de la vessie
WO1997006259A3 (fr) Resistance aux champignons provoquant la fletrissure
EP0824150A3 (fr) Promoteur végétal et son utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase